An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein.
Prion diseases are neurodegenerative conditions characterized by the conformational conversion of the cellular prion protein (PrPC), an endogenous membrane glycoprotein of uncertain function, into PrPSc, a pathological isoform that replicates by imposing its abnormal folding onto PrPC molecules. A g...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2017-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182589&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850076416955121664 |
|---|---|
| author | Claudia Stincardini Tania Massignan Silvia Biggi Saioa R Elezgarai Valeria Sangiovanni Ilaria Vanni Michael Pancher Valentina Adami Jorge Moreno Matteo Stravalaci Giulia Maietta Marco Gobbi Alessandro Negro Jesús R Requena Joaquín Castilla Romolo Nonno Emiliano Biasini |
| author_facet | Claudia Stincardini Tania Massignan Silvia Biggi Saioa R Elezgarai Valeria Sangiovanni Ilaria Vanni Michael Pancher Valentina Adami Jorge Moreno Matteo Stravalaci Giulia Maietta Marco Gobbi Alessandro Negro Jesús R Requena Joaquín Castilla Romolo Nonno Emiliano Biasini |
| author_sort | Claudia Stincardini |
| collection | DOAJ |
| description | Prion diseases are neurodegenerative conditions characterized by the conformational conversion of the cellular prion protein (PrPC), an endogenous membrane glycoprotein of uncertain function, into PrPSc, a pathological isoform that replicates by imposing its abnormal folding onto PrPC molecules. A great deal of evidence supports the notion that PrPC plays at least two roles in prion diseases, by acting as a substrate for PrPSc replication, and as a mediator of its toxicity. This conclusion was recently supported by data suggesting that PrPC may transduce neurotoxic signals elicited by other disease-associated protein aggregates. Thus, PrPC may represent a convenient pharmacological target for prion diseases, and possibly other neurodegenerative conditions. Here, we sought to characterize the activity of chlorpromazine (CPZ), an antipsychotic previously shown to inhibit prion replication by directly binding to PrPC. By employing biochemical and biophysical techniques, we provide direct experimental evidence indicating that CPZ does not bind PrPC at biologically relevant concentrations. Instead, the compound exerts anti-prion effects by inducing the relocalization of PrPC from the plasma membrane. Consistent with these findings, CPZ also inhibits the cytotoxic effects delivered by a PrP mutant. Interestingly, we found that the different pharmacological effects of CPZ could be mimicked by two inhibitors of the GTPase activity of dynamins, a class of proteins involved in the scission of newly formed membrane vesicles, and recently reported as potential pharmacological targets of CPZ. Collectively, our results redefine the mechanism by which CPZ exerts anti-prion effects, and support a primary role for dynamins in the membrane recycling of PrPC, as well as in the propagation of infectious prions. |
| format | Article |
| id | doaj-art-d848ba388733427eb03e624f9acc04d2 |
| institution | DOAJ |
| issn | 1932-6203 |
| language | English |
| publishDate | 2017-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj-art-d848ba388733427eb03e624f9acc04d22025-08-20T02:46:01ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01128e018258910.1371/journal.pone.0182589An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein.Claudia StincardiniTania MassignanSilvia BiggiSaioa R ElezgaraiValeria SangiovanniIlaria VanniMichael PancherValentina AdamiJorge MorenoMatteo StravalaciGiulia MaiettaMarco GobbiAlessandro NegroJesús R RequenaJoaquín CastillaRomolo NonnoEmiliano BiasiniPrion diseases are neurodegenerative conditions characterized by the conformational conversion of the cellular prion protein (PrPC), an endogenous membrane glycoprotein of uncertain function, into PrPSc, a pathological isoform that replicates by imposing its abnormal folding onto PrPC molecules. A great deal of evidence supports the notion that PrPC plays at least two roles in prion diseases, by acting as a substrate for PrPSc replication, and as a mediator of its toxicity. This conclusion was recently supported by data suggesting that PrPC may transduce neurotoxic signals elicited by other disease-associated protein aggregates. Thus, PrPC may represent a convenient pharmacological target for prion diseases, and possibly other neurodegenerative conditions. Here, we sought to characterize the activity of chlorpromazine (CPZ), an antipsychotic previously shown to inhibit prion replication by directly binding to PrPC. By employing biochemical and biophysical techniques, we provide direct experimental evidence indicating that CPZ does not bind PrPC at biologically relevant concentrations. Instead, the compound exerts anti-prion effects by inducing the relocalization of PrPC from the plasma membrane. Consistent with these findings, CPZ also inhibits the cytotoxic effects delivered by a PrP mutant. Interestingly, we found that the different pharmacological effects of CPZ could be mimicked by two inhibitors of the GTPase activity of dynamins, a class of proteins involved in the scission of newly formed membrane vesicles, and recently reported as potential pharmacological targets of CPZ. Collectively, our results redefine the mechanism by which CPZ exerts anti-prion effects, and support a primary role for dynamins in the membrane recycling of PrPC, as well as in the propagation of infectious prions.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182589&type=printable |
| spellingShingle | Claudia Stincardini Tania Massignan Silvia Biggi Saioa R Elezgarai Valeria Sangiovanni Ilaria Vanni Michael Pancher Valentina Adami Jorge Moreno Matteo Stravalaci Giulia Maietta Marco Gobbi Alessandro Negro Jesús R Requena Joaquín Castilla Romolo Nonno Emiliano Biasini An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein. PLoS ONE |
| title | An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein. |
| title_full | An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein. |
| title_fullStr | An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein. |
| title_full_unstemmed | An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein. |
| title_short | An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein. |
| title_sort | antipsychotic drug exerts anti prion effects by altering the localization of the cellular prion protein |
| url | https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0182589&type=printable |
| work_keys_str_mv | AT claudiastincardini anantipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT taniamassignan anantipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT silviabiggi anantipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT saioarelezgarai anantipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT valeriasangiovanni anantipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT ilariavanni anantipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT michaelpancher anantipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT valentinaadami anantipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT jorgemoreno anantipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT matteostravalaci anantipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT giuliamaietta anantipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT marcogobbi anantipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT alessandronegro anantipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT jesusrrequena anantipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT joaquincastilla anantipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT romolononno anantipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT emilianobiasini anantipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT claudiastincardini antipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT taniamassignan antipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT silviabiggi antipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT saioarelezgarai antipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT valeriasangiovanni antipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT ilariavanni antipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT michaelpancher antipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT valentinaadami antipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT jorgemoreno antipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT matteostravalaci antipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT giuliamaietta antipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT marcogobbi antipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT alessandronegro antipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT jesusrrequena antipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT joaquincastilla antipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT romolononno antipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein AT emilianobiasini antipsychoticdrugexertsantiprioneffectsbyalteringthelocalizationofthecellularprionprotein |